PortfoliosLab logoPortfoliosLab logo
CV vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CV vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CapsoVision, Inc (CV) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CV achieves a -43.97% return, which is significantly lower than LLY's 10.97% return.


CV

1D
3.81%
1M
-16.69%
6M
-1.80%
YTD
-43.97%
1Y
31.07%
3Y*
5Y*
10Y*

LLY

1D
-2.33%
1M
4.91%
6M
12.13%
YTD
10.97%
1Y
50.94%
3Y*
40.33%
5Y*
39.60%
10Y*
33.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CV vs. LLY - Yearly Performance Comparison


2026 (YTD)2025
CV
CapsoVision, Inc
-43.97%113.80%
LLY
Eli Lilly and Company
10.97%39.02%

Correlation

The correlation between CV and LLY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2025

0.08

Fundamentals

Market Cap

CV:

$299.28M

LLY:

$1.12T

EPS

CV:

-$0.24

LLY:

$28.16

PS Ratio

CV:

49.94

LLY:

14.77

PB Ratio

CV:

14.06

LLY:

34.13

Total Revenue (TTM)

CV:

$13.56M

LLY:

$72.25B

Gross Profit (TTM)

CV:

$7.01M

LLY:

$59.75B

EBITDA (TTM)

CV:

-$19.70M

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CV vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CV
CV Risk / Return Rank: 6060
Overall Rank
CV Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
CV Sortino Ratio Rank: 6565
Sortino Ratio Rank
CV Omega Ratio Rank: 6363
Omega Ratio Rank
CV Calmar Ratio Rank: 5858
Calmar Ratio Rank
CV Martin Ratio Rank: 5656
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 8080
Overall Rank
LLY Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7878
Sortino Ratio Rank
LLY Omega Ratio Rank: 7979
Omega Ratio Rank
LLY Calmar Ratio Rank: 8181
Calmar Ratio Rank
LLY Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CV vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CapsoVision, Inc (CV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CVLLYDifference
Sharpe ratioReturn per unit of total volatility

-1.00

Sortino ratioReturn per unit of downside risk

-0.68

Omega ratioGain probability vs. loss probability

1.15

1.26

-0.11

Calmar ratioReturn relative to maximum drawdown

0.49

2.23

-1.74

Martin ratioReturn relative to average drawdown

0.80

5.56

-4.76

CV vs. LLY - Sharpe Ratio Comparison

The current CV Sharpe Ratio is 0.34, which is lower than the LLY Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of CV and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CV vs. LLY - Drawdown Comparison

The maximum CV drawdown since its inception was -67.82%, roughly equal to the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for CV and LLY.


Loading charts...

Drawdown Indicators


CVLLYDifference

Max Drawdown

Largest peak-to-trough decline

-67.82%

-68.24%

+0.42%

Max Drawdown (1Y)

Largest decline over 1 year

-67.82%

-23.18%

-44.64%

Max Drawdown (3Y)

Largest decline over 3 years

-34.48%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

Current Drawdown

Current decline from peak

-58.46%

-3.80%

-54.66%

Average Drawdown

Average peak-to-trough decline

-33.81%

-19.19%

-14.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

41.35%

9.27%

+32.08%

Volatility

CV vs. LLY - Volatility Comparison

CapsoVision, Inc (CV) has a higher volatility of 27.01% compared to Eli Lilly and Company (LLY) at 9.93%. This indicates that CV's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CVLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.01%

9.93%

+17.08%

Volatility (6M)

Calculated over the trailing 6-month period

64.44%

27.64%

+36.80%

Volatility (1Y)

Calculated over the trailing 1-year period

99.57%

38.71%

+60.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

106.82%

32.51%

+74.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.82%

30.30%

+76.52%

Dividends

CV vs. LLY - Dividend Comparison

CV has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.54%.


PositionTTM20252024202320222021202020192018201720162015
CV
CapsoVision, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.54%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

CV vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between CapsoVision, Inc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
2.79M
19.80B
(CV) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CV and LLY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CV has higher volatility (27.01%) compared to LLY (9.93%). In terms of maximum drawdown, CV dropped -67.82% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.33 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CV and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer